Creso Pharma (ASX:CPH) share price spikes on bonus options issue

An interesting move from the cannabis player's arsenal today.

| More on:
two men in formal business clothing closely inspect a bud from a cannabis crop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Creso Pharma Ltd (ASX: CPH) share price is gaining ground in early trading, currently up around 9% at 12 cents apiece.

Creso Pharma shares are on the move as the company released a prospectus today, amid an acquisition that was completed yesterday.

Here are the details out of the medicinal cannabis company's corner today.

What was announced?

Creso released a 'bonus issue prospectus' relating to the issue of 'bonus options' to its shareholders which, it suggests, "should be considered as highly speculative".

Specifically, the document proposes "a bonus issue of one [bonus] option for every three shares held by those eligible [Creso] shareholders registered at the record date".

Creso will not receive or raise any funds for the offer, which begs the question – why offer the options in the first place?

The company gives a lengthy explanation of this. It states one purpose is to "reward shareholders for supporting the company". If only more companies did the same.

However, it appears there is a more pertinent reasoning behind the bonus option issuance.

The options can, in fact, act as a potential source of funding for the company if they are exercised. Under the stipulations, Creso will receive 25 cents for each bonus option exercised, with a total of almost 642 million options on issue.

So, while no funds will be raised directly through the issue of the bonus options, if they are all exercised, the company will receive approximately $99.9 million.

That's a substantial jump from the company's cash balance of around $16 million recorded in its half-yearly report in August.

One other benefit of the options strategy is it removes any "trading restrictions attaching to shares issued on exercise of the bonus options issued".

This effectively enables the option holders to trade the securities on any ASX market that allows options trading.

Building from half-yearly headwinds

As a result of its half-year financial performance to 30 June 2021, Creso incurred a substantial net loss and loss on cash flow from operations.

At the time, Creso disclosed there was a material uncertainty related to "events or conditions that may cast significant doubt upon the group's ability to continue as a going concern".

Hence, the company has pulled many strings these past few months to ensure it remains afloat and continues trading.

Measures to preserve cash and liquidity have now started to come through. As such, the board "continues to consider that the company will be able to continue" as a going concern.

It appears the company's move today serves as prudent capital management and gives the company a liquidity buffer if earnings and/or cash levels take a dent.

The announcement also follows an acquisition announcement yesterday where the company is seeking to strengthen its existing business and diversify operations.

Creso purchased Canadian life sciences company ImpACTIVE which has expertise in CBD-based medicinal products.

It acquired the company on a scrip purchase of $217,000 in Creso shares, valued at 11 cents per share.

The deal widens Creso's footprint in North America and also increases its CBD exposure in those markets.

Creso Pharma share price snapshot

The Creso Pharma share price has struggled this year to date, having posted a loss of 33.3% since January 1.

Despite this, it has still soared by more than 328% in the last 12 months. This return has outpaced the S&P/ASX 200 Index (ASX: XJO)'s climb of around 21% in that time.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Gainers

Rising gold share price represented by a green arrow on piles of gold block.
Share Gainers

2 ASX All Ords stocks that would already have more than doubled your money this year

These ASX All Ords stocks have gained 126% and 145% year to date. But how?

Read more »

Ten smiling business people wave to the camera after receiving some winning company news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an historic day for the ASX, with the market setting a new record.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Fletcher Building, Johns Lyng, Pilbara Minerals, and Zip shares are charging higher

These shares are having a strong session on hump day. But why?

Read more »

A cool dude looks back at the camera while ziplining above the treetops.
BNPL shares

Zip share price rockets 19% on full-year earnings upgrade

Surging again today, Zip shares are now up 127% since their recent April lows.

Read more »

happy teenager using iPhone
Share Gainers

Up 96% since April, should I still buy Life360 shares today?

A leading expert offers his verdict on the growth outlook for the surging Life360 share price.

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a lucrative return to trading for investors this Tuesday.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Austal, Botanix, DroneShield, and NextDC shares are storming higher today

These shares are starting the week with a bang. But why?

Read more »

A female coal miner wearing a white hardhat and orange high-vis vest holds a lump of coal and smiles as the Whitehaven Coal share price rises today
Share Gainers

The Coronado Global share price just surged to a 114% weekly gain. Here's why

Investors have sent the ASX coal stock flying higher in June. But why?

Read more »